In this interview, Dr Ryan Stidham discusses the various ways in which artificial intelligence is being used to streamline ...

Objective Growing evidence suggests that coeliac disease (CeD) is more common in patients with inflammatory bowel disease ...

The use of digital health technology (DHT) is increasing worldwide. Clinical trials assessing available health tools for the ...

Among Medicare beneficiaries with IBD, Black, Asian, and Hispanic patients have lower health care utilization patterns than White patients.

Hepatitis is an inflammation of the liver, most commonly caused by a viral infection. The three main types: Hepatitis A, B, ...

Irritable bowel syndrome (IBS) and small intestinal bacterial overgrowth (SIBO) affect the digestive tract and cause symptoms ...

SAN DIEGO — In tough-to-treat chronic inflammatory bowel disease (IBD), a precision-medicine strategy based on patients’ molecular profiles showed efficacy in guiding anti–tumor necrosis ...

A new drug delivery method could improve treatments for inflammatory bowel disease (IBD) like ulcerative colitis and Crohn’s disease. Currently available oral drugs for IBD must transit the ...

BMS is steadily building a position in IBD through drugs like oral S1P receptor modulator Zeposia (ozanimod), approved for ulcerative colitis as well as multiple sclerosis, and experimental TYK2 ...

An evaluation of nearly 19,000 patients with metastatic colorectal cancer supported clinical trial data that immunotherapy significantly extended OS compared with chemotherapy for those with ...

Major Cause of Inflammatory Bowel Disease Discovered June 5, 2024 — Researchers have discovered a new biological pathway that is a principal driver of inflammatory bowel disease (IBD ...

The treatment landscape of Inflammatory Bowel Disease (IBD) has undergone a significant transformation over the past two decades. Historically, therapeutic strategies primarily focused on ...